Etolotifen

This classification denotes a histamine-1 receptor antagonist with the molecular formula C24H29NO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U64HJ4AK57, chemically known as 4,9-dihydro-4-(1-(2-(-2(2-hydroxyethoxy)ethoxy)ethyl)-4-piperidylidene)-10h-ben-zo(4,5)cyclohepta(1,2-b)thiophen-10-one. but generally known as etolotifen, which bears US NIH Compound Identifier 208944. European Medicines Agency schedules Etolotifen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07328MIG. The term ETOLOTIFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). ETOLOTIFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etolotifen under HS 29349990 and SITC 51579. As of Q4 2014, ETOLOTIFEN remains the US FDA Preferred Term for this commodity. Etolotifen bears US NLM identifiers UMLS ID C1880587 and NCI Concept Code C65593. SMILES: S1C2C(C(=C3\CCN(CC3)CCOCCOCCO)\C3C(CC2=O)CCCC3)CC1.